A new series of 2-alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as adenosine receptor antagonists.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Chemical and pharmaceutical bulletin

• Publication date

  2011-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/CPB.59.730PMID 21628909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and Reactivity of [1,2,4]Triazolo-annelated Quinazolines

  2010cited by this paper
• Novel Synthesis of 2-Alkoxy(aralkoxy)-5-chloro[1,2,4]triazolo[1,5-a]quinazolines and Their Derivatives.

  2010cited by this paper
• Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility.

  2008cited by this paper
• Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy.

  2008cited by this paper
• Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists.

  2006cited by this paper
• 4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.

  2006cited by this paper
• Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.

  2005cited by this paper
• 1,2,4-Triazolo[1,5-a]quinoxaline as a Versatile Tool for the Design of Selective Human A3 Adenosine Receptor Antagonists: Synthesis, Biological Evaluation, and Molecular Modeling Studies of 2-(Hetero)aryl- and 2-Carboxy-Substitued Derivatives

  2005cited by this paper
• 1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.

  2005cited by this paper
• 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.

  2004cited by this paper
• 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.

  2004cited by this paper
• 3-Phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and Analogues: High-Affinity γ-Aminobutyric Acid-A Benzodiazepine Receptor Ligands with α2, α3, and α5-Subtype Binding Selectivity over α1

  2004cited by this paper
• Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.

  2004cited by this paper
• [3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors.

  2004cited by this paper
• 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.

  2004cited by this paper
• 8-Substituted-9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B.

  2004cited by this paper
• Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson’s disease

  2003cited by this paper
• Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.

  2003cited by this paper
• Renal effects of BG9928, an A1 adenosine receptor antagonist, in rats and nonhuman primates

  2003cited by this paper
• 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.

  2002cited by this paper
• Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist.

  2002cited by this paper
• [(3)H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([(3)H]PSB-11), a novel high-affinity antagonist radioligand for human A(3) adenosine receptors.

  2002cited by this paper
• [3H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1h-imidazo[2,1-i]-purin-5- one ([3H]PSB-11), a novel high-affinity antagonist radioligand for human A3 adenosine receptors

  2002cited by this paper
• Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.

  2002cited by this paper
• Selective adenosine A2A receptor antagonists.

  2001cited by this paper
• Substituted 1,2,3-triazolo[1,5-a]quinazolines: synthesis and binding to benzodiazepine and adenosine receptors.

  2000cited by this paper
• Adenosine receptors in neurological disorders

  2000cited by this paper
• GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors.

  2000cited by this paper
• Structure and function of adenosine receptors and their genes

  2000cited by this paper
• [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.

  2000cited by this paper
• Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.

  2000cited by this paper
• The role of receptor structure in determining adenosine receptor activity.

  2000cited by this paper
• 4‐Amino‐6‐benzylamino‐1,2‐dihydro‐2‐phenyl‐1,2,4‐triazolo[4,3‐α]‐quinoxalin‐1‐one: A New A2A Adenosine Receptor Antagonist with High Selectivity versus A1 Receptors

  1999cited by this paper
• Receptors for purines and pyrimidines.

  1998cited by this paper
• Tricyclic Heteroaromatic Systems. 1,2,4‐Triazolo[4,3‐a]quinoxalines and 1,2,4‐Triazino[4,3‐a]quinoxalines: Synthesis and Central Benzodiazepine Receptor Activity

  1998cited by this paper
• Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

  1998cited by this paper
• Adenosine receptors: new opportunities for future drugs.

  1998cited by this paper
• Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.

  1997cited by this paper
• Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.

  1996cited by this paper
• Tricyclic Heteroaromatic Systems. 1,2,4‐Triazolo(1,5‐a)quinoxalines ( IV), (VI), (VII): Synthesis and Benzodiazepine Receptor Activity.

  1995cited by this paper
• Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines.

  1995cited by this paper
• Synthesis of some tricyclic heteroaromatic systems and their A1 and A2a adenosine binding activity

  1995cited by this paper
• Nomenclature and classification of purinoceptors.

  1994cited by this paper
• The binding of 1,3‐[3H]‐dipropyl‐8‐cyclopentylxanthine to adenosine Ai receptors in rat smooth muscle preparations

  1994cited by this paper
• Tricyclic heteroaromatic systems pyrazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity.

  1993cited by this paper
• Adenosine receptor subtypes.

  1993cited by this paper
• Tricyclic heteroaromatic systems 1,2,4-triazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity.

  1993cited by this paper
• Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

  1992cited by this paper
• Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.

  1988cited by this paper
• 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) — a selective high affinity antagonist radioligand for A1 adenosine receptors

  1987cited by this paper
• Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.

  1985cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• ArticleDFT calculation

  2021cites this paper
• DFT Calculation, Hirshfeld Analysis and X-Ray Crystal Structure of Some Synthesized N-alkylated(S-alkylated)-[1,2,4]triazolo[1,5-a]quinazolines

  2021cites this paper
• An overview of triazoloquinazolines: Pharmacological significance and recent developments.

  2021cites this paper
• 1,2,4-Triazolo[5,1-b]- and -[1,5-a]quinazolines and their hydro derivatives

  2021cites this paper
• PREPARATION OF BENZOXAZENE DERIVATIVES FROM THE REACTION OF UNSATURATED KETONE ACIDS WITH ANTHRANILIC ACID

  2020cites this paper
• Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies

  2020cites this paper
• Synthesis and antioxidant activity of 2-methylthio-pyrido[3,2-e][1,2,4] triazolo[1,5-a]pyrimidines

  2019cites this paper
• Synthesis, Antimicrobial and Anti-inflammatory Activity of Some New Benzoxazinone and Quinazolinone Candidates.

  2016cites this paper
• Antimicrobial Activity of Synthesized 2-Methylthiobenzo[g][1,2,4]- triazolo[1,5-a]quinazoline Derivatives.

  2016cites this paper
• Synthesis of Novel 2-(Methylthio)benzo(g)(1,2,4)triazolo(1,5-a)quinazolin- 5-(4H)-one and its Derivatives

  2014cites this paper
• Biological effects of a new set 1,2,4-triazolo[1,5-a]quinazolines on heart rate and blood pressure

  2014cites this paper
• An efficient one-pot synthesis of 1,2,4-triazoloquinoxalines

  2014cites this paper
• 2-Methylsulfanyl-1,2,4-triazolo[1,5-a]quinazoline-5(4H)-thione

  2013cites this paper
• Antimicrobial activity of newly synthesized methylsulfanyl‐triazoloquinazoline derivatives

  2013cites this paper
• Antiviral activities of some synthesized methylsulfanyltriazoloquinazoline derivatives

  2013cites this paper
• Cytotoxicity and Anti-Inflammatory Activity of Methylsulfanyl-triazoloquinazolines

  2013cites this paper
• Clindamycin in Treatment of Lung Abscess in Children

  2012cites this paper
• A New Series of 2‐Alkoxy(aralkoxy)‐[1,2,4]triazolo[1,5‐a]quinazolin‐5‐ones as Adenosine Receptor Antagonists.

  2011cites this paper
• 2-Ethoxy-5-methylbis[1,2,4]triazolo[1,5-a:4′,3′-c]quinazoline

  2011cites this paper
• Cytotoxic and Anti-Inflammatory Active Methylsulfanyltriazoloquinazolines

  year unknowncites this paper